-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-41 Immune Monitoring in Myeloma

Program: Scientific Program
Session: The Immune System in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Diseases, smoldering myeloma, Plasma Cell Disorders, Lymphoid Malignancies
Monday, December 7, 2020, 11:25 AM-11:30 AM

Madhav V. Dhodapkar, MBBS

Emory University, Atlanta, GA

Disclosures: Dhodapkar: Kite: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Lava Therapeutics: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Amgen: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Celgene/BMS: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Janssen: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Roche/Genentech: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board.

<< Previous Presentation | Next Presentation